
Edap Tms S.a.
Edap Tms S.a. (EDAP) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · EDAP · as of Sep 30, 2025
Ownership Breakdown
38
Institutional Holders
$31.69M
Total Inst. Value
▲ $8.44M vs Q2
37.48M
Shares Outstanding
freeFloat 99.47%
13.83M
13F Shares Held
▼ 265,789 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
EDAP largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
SOLEUS CAPITAL MANAGEMENT, L.P. electromedical & electrotherapeutic apparatus | 7.31M | 19.55% | 19.55% | $16.74B | Nov 14, 2025 | — held |
MORGAN STANLEY electromedical & electrotherapeutic apparatus | 3.36M | 8.99% | 8.99% | $7.70B | May 27, 2026 | ▼ 2.8K |
ROCK SPRINGS CAPITAL MANAGEMENT LP electromedical & electrotherapeutic apparatus | 1.27M | 3.40% | 3.40% | $2.91B | Nov 14, 2025 | — held |
BRUCE & CO., INC. electromedical & electrotherapeutic apparatus | 438.7K | 1.17% | 1.17% | $1.01B | Nov 13, 2025 | ▼ 115.0K |
UBS GROUP AG electromedical & electrotherapeutic apparatus | 238.2K | 63.71% | 63.71% | $545.52M | Nov 13, 2025 | ▲ 59.8K |
SCHONFELD STRATEGIC ADVISORS LLC electromedical & electrotherapeutic apparatus | 170.1K | 45.48% | 45.48% | $389.43M | Nov 14, 2025 | ▼ 2.1K |
PARKMAN HEALTHCARE PARTNERS LLC electromedical & electrotherapeutic apparatus | 154.8K | 41.41% | 41.41% | $354.56M | Nov 14, 2025 | — held |
CAHILL FINANCIAL ADVISORS INC electromedical & electrotherapeutic apparatus | 135.0K | 36.09% | 36.09% | $309.06M | Nov 3, 2025 | — held |
SUMMIT TRAIL ADVISORS, LLC electromedical & electrotherapeutic apparatus | 102.3K | 27.37% | 27.37% | $234.36M | Nov 14, 2025 | — held |
CITADEL ADVISORS LLC electromedical & electrotherapeutic apparatus | 101.4K | 27.12% | 27.12% | $234.23M | Nov 14, 2025 | ▲ 13.5K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
5
Increased
+122.0K shares3
New Positions
first time holders9
Decreased
−182.9K shares3
Sold Out
fully exitedNet shares change (top 50)
60.9K
+122.0K / −182.9K
Net new holders
-4
3 new / 3 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
EDAP insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
10
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Annen Steven SVP, Marketing & Product Mgmt. | May 12, 2026 | Award | 90,000 | — | — | 131.5K | Form 4 ↗ |
Annen Steven SVP, Marketing & Product Mgmt. | May 12, 2026 | Award | 100,000 | $4.17 | $417.0K | 100.0K | Form 4 ↗ |
Shah Sanket Gen Counsel & Corp Secretary | May 12, 2026 | Award | 75,000 | $4.17 | $312.8K | 75.0K | Form 4 ↗ |
Shah Sanket Gen Counsel & Corp Secretary | May 12, 2026 | Award | 67,500 | — | — | 67.5K | Form 4 ↗ |
Rhodes Ryan Chief Executive Officer | May 12, 2026 | Award | 304,500 | — | — | 605.6K | Form 4 ↗ |
Rhodes Ryan Chief Executive Officer | May 12, 2026 | Award | 390,000 | $4.17 | $1.63M | 390.0K | Form 4 ↗ |
WILLSEY LANCE director | May 12, 2026 | Award | 114,285 | $4.17 | $476.6K | 114.3K | Form 4 ↗ |
Mobeck Kenneth S. Chief Financial Officer | May 12, 2026 | Award | 120,000 | — | — | 176.6K | Form 4 ↗ |
Mobeck Kenneth S. Chief Financial Officer | May 12, 2026 | Award | 144,141 | $4.17 | $601.1K | 144.1K | Form 4 ↗ |
LEVINE JOSHUA director | May 11, 2026 | Purchase | 10,000 | $4.22 | $42.2K | 35.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Edap Tms S.a. (EDAP) is primarily owned by institutional investors, who hold approximately 36.9% of total shares outstanding. Company insiders own approximately 0.53%, while retail and public investors account for the remaining 62.55%.
The largest institutional shareholder of Edap Tms S.a. is SOLEUS CAPITAL MANAGEMENT, L.P., holding approximately 7.31 million shares — equal to 19.55% of outstanding shares — as of September 30, 2025.
A total of 38 institutional investors currently hold EDAP stock, with a combined institutional value of approximately $31,694,969 as of the most recent 13F filing period.
Frequently asked questions
EDAP ownershipEdap Tms S.a. (EDAP) is primarily owned by institutional investors, who hold approximately 36.9% of shares. The largest shareholder is SOLEUS CAPITAL MANAGEMENT, L.P. with a 19.55% stake. Company insiders hold 0.53%. Data sourced from SEC Form 13F as of September 30, 2025.